Valiant Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Valiant Laboratories Limited has submitted to the exchanges copies of the newspaper publication of its Standalone and Consolidated Audited Financial Results for the quarter ended June 30, 2025, published in The Financial Express and Mumbai Lakshadeep on August 9, 2025. On a standalone basis, the company reported total operating income of Rs 5,167.85 lakhs and net profit after tax of Rs 181.57 lakhs, with EPS of Rs 0.42. On a consolidated basis, total income stood at Rs 4,747.81 lakhs and net profit after tax at Rs 182.09 lakhs. Year-on-year, the company has turned around from a loss of Rs 100.56 lakhs in Q1 FY25 to a profit of Rs 181.57 lakhs in Q1 FY26, while revenue has more than doubled from Rs 2,105.80 lakhs. Sequentially, however, revenue declined from Rs 5,842.39 lakhs in Q4 FY25. The results were approved by the Board on August 8, 2025.
The sharp YoY swing from loss to profit and more than doubling of revenue is a positive signal for shareholders, though the sequential revenue dip and the full-year FY25 loss of Rs 215.02 lakhs on a standalone basis suggest recovery is still in early stages. Near-term stock reaction is likely to depend on whether the YoY momentum sustains.